WithdrawnPhase 4

Avastin for Post-photocoagulation Macular Edema

Stopped: undefined

Mexico0Started 2008-12

Plain-language summary

to evaluate the efficacy of a single intravitreal bevacizumab (IVB) injection, 0.1mL (2.5mg), against panretinal photocoagulation (PRP)-induced macular thickening and visual disturbance in patients with severe nonproliferative diabetic retinopathy (NPDR) and proliferative diabetic retinopathy (PDR) and good vision

Who can participate

Age range15 Years – 80 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Patients with Proliferative retinopathy or severe non-proliferative retinopathy * BCVA of 20/63 or better (56 ETDRS letters * No history of Macular Edema * Central Retinal Thickness of 250mics or more Exclusion Criteria: * Previous treatment. * Other ophthalmic diseases. history of Nephropathy, heart diseases and pregnancy * Media opacities

What they're measuring

Best Corrected Visual Acuity

Trial details

NCT IDNCT00801866

SponsorAsociación para Evitar la Ceguera en México

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2008-12

View on ClinicalTrials.gov More Macular Edema trials